ALTME:EPA
TME Pharma NV
€ ०.११
arrow_downward
-१.९८%(-०.००२२) 1D
अक्टोबर २०, १७:१५:२३ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALTME...
Open
€ ०.११
High
€ ०.११
Low
€ ०.१०
Mkt. cap
१.०४ करोड
Avg. vol.
१८.५४ लाख
Volume
१.६२ लाख
52-wk high
€ ०.१७
52-wk low
€ ०.०५
EPS
-€ ०.०३
No. of employees
०
Open
€ ०.११
High
€ ०.११
Low
€ ०.१०
Mkt. cap
१.०४ करोड
Avg. vol.
१८.५४ लाख
Volume
१.६२ लाख
52-wk high
€ ०.१७
52-wk low
€ ०.०५
EPS
-€ ०.०३
No. of employees
०
News stories
From web sources and news partners
AP News
·
१ घण्टा पहिले
Curfews bring calm to Paris as France cracks down on weekend rioters
Yahoo Finance
·
२ घण्टा पहिले
Trex Company to Ring NYSE Opening Bell in Celebration of 30th Anniversary
Elko Daily Free Press
·
३५ मिनेट पहिले
Lion Copper shares now listed on Nasdaq
Profile
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
About TME Pharma NV